MedPath
HSA Approval

AXCEL CETIRIZINE SYRUP 5MG/5ML

SIN14690P

AXCEL CETIRIZINE SYRUP 5MG/5ML

AXCEL CETIRIZINE SYRUP 5MG/5ML

December 4, 2014

KOTRA PHARMA MARKETING

KOTRA PHARMA MARKETING

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantKOTRA PHARMA MARKETING
Licence HolderKOTRA PHARMA MARKETING

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

LIQUID

ORAL

Medical Information

R06AE07

cetirizine

Manufacturer Information

KOTRA PHARMA MARKETING

KOTRA PHARMA (M) SDN BHD

Active Ingredients

CETIRIZINE DIHYDROCHLORIDE

5MG/5ML

Cetirizine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AXCEL CETIRIZINE SYRUP 5MG/5ML - HSA Approval | MedPath